Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 3 of 3 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Efficacy, Safety and Tolerability Study of Glatiramer Acetate in Subjects With Multiple Sclerosis
- Condition(s):
- Relapsing-Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Glatiramer Acetate | Drug: Placebo
Glatiramer Acetate Follow-up in Participants From the Original Study for Safety and Effectiveness
- Condition(s):
- Relapsing-Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: Glatiramer acetate
Safety and Tolerability of Glatiramer Acetate (GLACIER)
- Condition(s):
- Relapsing-Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: GA 20 mg/mL | Drug: GA 40 mg/mL